Immune responses to varicella-zoster virus

Infectious Disease Clinics of North America

Volumn 10, Issue 3, 1996, Pages 529-570

  Arvin, A M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; HERPES ZOSTER IMMUNOGLOBULIN; LIVE VACCINE; VIRUS PROTEIN;

CELLULAR IMMUNITY; CHICKENPOX; DISEASE PREDISPOSITION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL MEMORY; PRIMARY IMMUNE RESPONSE; RECURRENT DISEASE; REVIEW; VARICELLA ZOSTER VIRUS;

EID: 0029841827     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70312-3     Document Type: Article

References (140)

1. A.M. Arbeter L. Granowetter S.E. Starr Immunization of children with acute lymphoblastic leukemia with live attenuated varicella vaccine without complete suspension of chemotherapy Pediatrics 85 1990 338
2. A.M. Arbeter S.E. Starr L. Baker Advances with the varicella vaccine Pediatr Res 19 1985 286A
3. A.M. Arbeter S.E. Starr S.A. Plotkin Varicella vaccine studies in healthy children and adults Pediatrics 78 1986 748
4. A.M. Arvin Cell-mediated immunity to varicella-zoster virus J Infect Dis 166 suppl 1 1992 S35
5. A.M. Arvin Varicella-zoster virus B. Fields Virology 1995 Raven Press New York 2547 2586
6. A.M. Arvin E. Kinney-Thomas K. Shriver Immunity to varicella-zoster viral glycoproteins, gp I (90/58) and gp III (gp 118) and to a nonglycosylated protein, p170 J Immunol 137 1986 1346
7. A.M. Arvin C.M. Koropchak Immunoglobulins M and G to varicella-zoster virus measured by solid phase radioimmunoassay: Antibody responses with varicella and herpes zoster infections J Clin Microbiol 12 1980 367
8. A.M. Arvin C.M. Koropchak B.R.G. Williams Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection J Infect Dis 154 1986 422
9. A.M. Arvin C.M. Koropchak A.E. Wittek Immunologic evidence for reinfection with varicella-zoster virus J Infect Dis 148 1983 200
10. A.M. Arvin J.H. Kushner S. Feldman Human leukocyte interferon for the treatment of varicella in children with cancer N Engl J Med 306 1982 761
11. A.M. Arvin R.B. Pollard L.E. Rasmussen Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma J Clin Invest 65 1980 869
12. A.M. Arvin M. Sharp S.M. Smith Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by CTLs of either CD4+ or CD8+ phenotype J Immunol 146 1991 257
13. Y. Asano N. Itakura Y. Hiroishi Viral replication and immunologic responses in children naturally infected with varicella-zoster and in varicella vaccine recipients J Infect Dis 152 1985 863
14. Y. Asano T. Nagai T. Miayto Persistence of protective immunity after inoculation with live varicella vaccine (Oka strain) Biken J 27 1984 123
15. Y. Asano H. Nakayama T. Yazaki Protection against varicella in family contacts by immediate inoculation with live varicella vaccine Pediatrics 59 1977 3
16. Y. Asano S. Suga T. Yoshikawa Experience and reason: Twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine Pediatrics 190 1994 524
17. R.E. Bergen P.S. Diaz A.M. Arvin The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content J Infect Dis 162 1990 1049
18. R.E. Bergen M. Sharp A. Sanchez Human T cells recognize multiple epitopes of a major tegument/immediate early protein (IE62) and glycoprotein I of varicella-zoster virus Viral Immunol 4 1991 151
19. S. Bogger-Goren K. Baba P. Hurley Antibody responses to varicella-zoster virus after natural or vaccine-induced infection J Infect Dis 146 1982 260
20. S. Bogger-Goren J.M. Bernstein A.A. Gershon Mucosal cell-mediated immunity to varicella-zoster virus: Role in protection against disease J Pediatr 105 1984 195
21. R.A. Bowden M.J. Levin R.H. Giller Lysis of varicella-zoster virus-infected cells by lymphocytes from normal humans and immunosuppressed pediatric leukemic patients Clin Exp Immunol 60 1985 387
22. P.A. Brunell A.A. Gershon S.A. Uduman Varicella-zoster immunoglobulins during varicella, latency, and zoster J Infect Dis 132 1975 49
23. P.A. Brunell V.M. Novelli P.M. Keller Antibodies to the three major glycoproteins of varicella-zoster virus: Search for the relevant host immune response J Infect Dis 156 1987 430
24. P.A. Brunell Z. Shehab C. Geiser Administration of live varicella vaccine to children with leukemia Lancet 2 1982 1069
25. B.L. Burke R.W. Steele O.W. Beard Immune responses to varicella-zoster virus in the aged Arch Intern Med 142 1982 291
26. J. Cohen S. Straus B. Fields Virology 1995 Raven Press New York 2525 2546
27. B.L. Connelly L.R. Stanberry D.I. Bernstein Detection of varicella-zoster virus DNA in nasopharyngeal secretions of immune household contacts of varicella J Infect Dis 168 1993 1253
28. E.C. Cooper L.K. Vujcic G.V. Quinnan Jr Varicella-zoster virus-specific HLA-restricted cytotoxicity of normal immune adult lymphocytes after in vitro stimulation J Infect Dis 158 1988 780
29. L.M. Cristofani A. Weinberg V. Peixoto Administration of live attenuated varicella vaccine to children with cancer before starting chemotherapy Vaccine 9 1991 873
30. A.L. Cunningham R.R. Turner A.C. Miller Evolution of recurrent herpes simplex virus lesions. An immunohistologic study J Clin Invest 75 1985 226
31. A.J. Davison Varicella-zoster virus. The Fourteenth Fleming lecture J Gen Virol 72 1991 475
32. P.H. Dennehy K.S. Reisinger M.M. Blatter Immunogenicity of subcutaneous versus intramuscular Oka/Merck varicella vaccination in healthy children Pediatrics 88 1991 604
33. P.H. Dennehy C.L. Saracen G. Peter Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection Pediatrics 88 1994 514
34. M.E. Devlin D.H. Gilden R. Mahalingam Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA J Infect Dis 165 1992 619
35. P.S. Diaz E.L. Hunter S.M. Smith T-lymphocyte Cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine J Immunol 142 1989 636
36. P.S. Diaz S.M. Smith E.L. Hunter Immunity to varicella-zoster virus antigen, glycoprotein I (gp I) and a non-glycosylated protein (p 170): Relation to the immunizing regimen of live attenuated varicella vaccine J Infect Dis 158 1988 1245
37. L. Dubey S.P. Steinberg P. LaRussa Western blot analysis of antibody to varicella-zoster virus J Infect Dis 157 1988 882
38. J.A. Englund C.S. Suarez J. Kelly Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine J Pediatr 114 1989 37
39. S.K.H. Foung S. Perkins C.M. Koropchak Human monoclonal antibodies neutralizing varicella-zoster virus J Infect Dis 152 1985 280
40. G. Gerna P.M. Cereda E. Cattaneo Antibody to early antigens of varicella-zoster virus during varicella and zoster J Infect Dis 140 1979 33
41. A.A. Gershon Human immune responses to live attenuated varicella vaccine Rev Infect Dis 13 suppl 11 1991 S957
42. A.A. Gershon Varicella vaccine: The American experience J Infect Dis 166 1992 51 63
43. A.A. Gershon S.P. Steinberg Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infection Infect Immune 25 1979 170
44. A.A. Gershon S.P. Steinberg Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine N Engl J Med 320 1989 892
45. A.A. Gershon S.P. Steinberg Live attenuated varicella vaccine: Protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group J Infect Dis 161 1990 661
46. A.A. Gershon S.P. Steinberg L. Gelb Clinical reinfection with varicella-zoster virus J Infect Dis 149 1984 137
47. A.A. Gershon S.P. Steinberg L. Gelb Live attenuated varicella vaccine: Efficacy for children with leukemia in remission JAMA 252 1984 355
48. A.A. Gershon S.P. Steinberg L. Gelb Live attenuated varicella vaccine use in immunocompromised children and adults Pediatrics 78S 1986 757
49. A.A. Gershon S.P. Steinberg P. LaRussa Immunization of healthy adults with live attenuated varicella vaccine J Infect Dis 158 1988 132
50. A.A. Gershon S.P. Steinberg N.J. Schmidt Varicella-zoster virus A. Balows W.J. Hauseler K.L. Herrman Manual of Clinical Microbiology 1991 American Society for Microbiology Washington, DC 838
51. A.A. Gershon S. Steinberg M. Smith Cell-mediated immunity to varicella-zoster virus demonstrated by viral inactivation with human leukocytes Infect Immun 13 1976 1549
52. R.H. Giller S. Winistorfer C. Grose Cellular and humoral immunity to varicella-zoster virus glycoproteins in immune and susceptible human subjects J Infect Dis 160 1989 919
53. E. Gold Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection N Engl J Med 274 1966 181
54. C. Grose Varicella-zoster virus: Pathogenesis of the human diseases, the virus and viral replication R. Hyman The Natural History of Varicella-Zoster virus 1987 CRC Press New York 1 66
55. C. Grose W.E. Friedrichs Immunoprecipitable polypeptides specified by varicella-zoster virus Virology 118 1982 86
56. C. Grose V. Litwin Immunology of the varicella-zoster virus glycoproteins J Infect Dis 157 1988 877
57. M.R. Hammerschlag A.A. Gershon S.P. Steinberg Herpes Zoster in an adult recipient of live attenuated varicella vaccine J Infect Dis 160 1989 535
58. D.R. Harper H.V. Kangro R.B. Heath Antibody responses in recipients of varicella vaccine assayed by immunoblotting J Med Virol 30 1990 61 67
59. F.A. Hayes S. Feldman Cell-mediated immunity to varicella-zoster virus in children being treated for cancer Cancer 42 1978 159
60. A.R. Hayward T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV J Virol 64 1990 65
61. A.R. Hayward M. Herberger Lymphocyte responses to varicella-zoster virus in the elderly J Clin Immunol 7 1987 174
62. A.R. Hayward M. Levin W. Wolf Varicella-zoster virus-specific immunity after herpes zoster J Infect Dis 163 1991 873
63. A.R. Hayward O. Pontesilli O. Herberger Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells J Virol 58 1986 179
64. A.R. Hayward E. Villanueba M. Cosyns Varicella-zoster virus (VZV)-specific cytotoxicity after immunization of nonimmune adults with Oka strain attenuated VZV vaccine J Infect Dis 166 1992 260
65. J.K. Hickling L.K. Borysiwicz J.G.P. Sissons Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): Detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood J Virol 61 1987 3463
66. Z. Huang A. Vafai J. Lee Specific lysis of targets expressing varicella-zoster virus gpI or gpIV by CD4 + human T-cell clones J Virol 66 1992 2664
67. T. Ihara T. Kato S. Torigoe Antibody response determined with antibody-dependent cell-mediated cytotoxicity (ADCC), neutralizing antibody, and varicella skin test in children with natural varicella and after varicella immunization Acts Paediatr Jpn 33 1991 43
68. T. Ihara S.E. Starr M. Ito Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts J Virol 51 1984 110
69. M. Ito S. Bandyopadhyay M. Matsumoto-Kobayashi Interleukin 2 enhances natural killing of varicella-zoster virus-infected targets Clin Exp Immunol 65 1986 182
70. C. Johnson L.P. Rome T. Stancin Humoral immunity and clinical reinfections following varicella vaccine in healthy children Pediatrics 84 1989 418
71. C.E. Johnson P.A. Shurin D. Fattlar Live attenuated varicella vaccine in healthy 12- to 24-month-old children Pediatrics 83 1988 512
72. C.F.R. Kallander J.S. Gronowitz E.G. Torfason Human serum antibodies to varicella-zoster virus thymidine kinase Infect Immun 36 1982 30
73. H. Kamiya T. Ihara A. Hattori Diagnostic skin test reactions with varicella virus antigen and clinical application of the test J Infect Dis 136 1977 784
74. P.M. Keller K. Lonergan B.J. Neff Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies J Virol Methods 14 1986 177
75. P.M. Keller B.J. Neff R.W. Ellis Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes J Virol 52 1984 293
76. P.R. Kinchington J. Houghland A.M. Arvin Varicella-zoster virus IE62 protein is a major virion component J Virol 66 1992 359
77. P.R. Kinchington P. Ling M. Pensiero The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka) J Virol 64 1990 4540
78. T. Kumagai Y. Chiba Y. Wataya Development and characteristics of the cellular immune response to infection with varicella-zoster virus J Infect Dis 141 1980 7
79. B.J. Kuter R.E. Weibel H.A. Guess Oka/Merck varicella vaccine in healthy children: Final report of a 2-year efficacy study and 7-year follow-up studies Vaccine 9 1991 643
80. B.J. Kuter A. Ngai C.M. Patterson Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults Vaccine 13 1995 967
81. M.L. Landry D. Ferguson Comparison of latex agglutination test with enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus J Clin Microbiol 30 1993 3031
82. M. Larkin J.E. Heckels M.M. Ogilvie Antibody response to varicella-zoster virus surface glycoproteins in chickenpox and shingles J Gen Virol 66 1985 1785
83. P. LaRussa S.P. Steinberg M.D. Seeman Determination of immunity to varicella-zoster virus by means of an intradermal skin test J Infect Dis 152 1985 869
84. M.J. Levin M. Murray H.A. Rotbart Immune response of elderly individuals to a live attenuated varicella vaccine J Infect Dis 166 1992 253
85. M.J. Levin M. Murray G.O. Zerbe Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine J Infect Dis 170 1994 522
86. E. Levy B. Mosovitz M. Friedman Detection of varicella-zoster virus-specific IgA antibodies in varicella and zoster patients and in healthy adults of various ages by solid phase radioimmunoassay Intervirology 2 1983 123
87. M.H. Mazur R.J. Whitley R. Dolin Serum antibody levels as risk factors in the dissemination of herpes zoster Arch Intern Med 139 1979 1341
88. T.C. Merigan J.G. Gallagher R.P. Pollard Short course interferon therapy in treatment of herpes zoster in cancer patients Antimicrob Agents Chemother 19 1981 193
89. T.C. Merigan K.H. Rand R.B. Pollard Human leukocyte interferon for the treatment of herpes zoster in patients with cancer N Engl J Med 298 1978 981
90. J.D. Meyers N. Flournoy E.D. Thomas Cell-mediated immunity to varicella-zoster virus after allogeneic bone marrow transplant J Infect Dis 141 1980 479
91. E. Miller J.E. Craddock-Watson M.K. Ridehalgh Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus Lancet 2 1989 371
92. S. Nader R. Bergen M. Sharp Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine Infect Dis 171 1995 13
93. Ngai AL, Staehle BO, Kuter BJ, et al: Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children. Submitted, 1995
94. T. Ozaki T. Matsui T. Ichikawa Clinical trial of the Oka strain of live attenuated varicella vaccine in healthy children Biken J 27 1984 39
95. T. Ozaki H. Miwata Y. Asano Varicella-zoster virus DNA in throat swabs of vaccines Arch Dis Child 267 1993 328
96. P.E. Palumbo A.M. Arvin C.M. Koropchak Investigation of the varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method J Gen Virol 65 1984 2141
97. P.A. Patel S. Yoonessi J. O'Malley Cell-mediated immunity to varicella-zoster virus infection in subjects with lymphoma and leukemia J Pediatr 94 1979 223
98. L.E. Patterson K.M. Butler M.S. Edwards Clinical herpes zoster shortly following primary varicella in two HIV-infected children Clin Pediatr 28 1989 354
99. P.J. Provost D.L. Krah B.J. Kuter Antibody assays suitable for assessing immune responses to live varicella vaccine Vaccine 9 1991 111
100. R. Redman Reconstitution of VZV immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine (abstract) Infect Dis Soc Am Oct 1996
101. J.E. Rodriguez T. Moninger C. Grose Entry and egress of varicella virus blocked by the same anti-gH monoclonal antibody Virology 196 1993 840
102. C.A.C. Ross R. McDaid Specific IgM antibody in serum of patients with herpes zoster infection BMJ 4 1972 522
103. J.C. Ruckdeschel S.C. Schimpff A.C. Smyth Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's disease Am J Med 62 1977 77
104. N.J. Schmidt A.M. Arvin Sensitivity of different assay systems for immunoglobulin M responses to varicella-zoster virus in reactivated infections (zoster) J Clin Microbiol 23 1986 978
105. N.J. Schmidt D. Gallo Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses J Med Virol 13 1984 1
106. N.J. Schmidt E.H. Lennette Neutralizing antibody responses to varicella-zoster virus Infect Immun 12 1975 606
107. M. Sharp K. Terada A. Wilson The kinetics and protein specificity of T-lymphocyte cytotoxicity in healthy adults immunized with live attenuated varicella vaccine J Infect Dis 165 1992 852
108. K. Shiraki K. Yamanishi M. Takahashi Biologic and immunologic characterization of the soluble skin-test antigen of varicella-zoster virus J Infect Dis 149 1984 501
109. S.J. Sperber B.V. Smith F.G. Hayden Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine Antiviral Res 17 1992 213
110. S.P. Steinberg A.A. Gershon Measurement of antibodies to varicella-zoster virus by using a latex agglutination test J Clin Microbiol 29 1991 1527
111. D.A. Stevens T.C. Merigan Zoster immune globulin prophylaxis of disseminated zoster in compromised hosts Arch Intern Med 140 1980 52
112. D.A. Stevens R.A. Ferrington G.W. Jordan Cellular events in zoster vesicles: Relation to clinical course and immune parameters J Infect Dis 131 1975 509
113. T. Sugano T. Tomiyama Y. Matsumoto A human monoclonal antibody against varicella-zoster virus glycoprotein III J Gen Virol 72 1991 2065
114. V.A. Sundqvist A. Linde B. Wahren Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections J Clin Microbiol 20 1984 94
115. M. Takahashi Clinical overview of varicella vaccine: Development and early studies Pediatrics 78 1986 736
116. M. Takahashi T. Iketani K. Sasada Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen J Infect Dis 140 1992 S58
117. M. Takahashi T. Otsuka Y. Okuno Live vaccine used to prevent the spread of varicella in children in hospital Lancet 2 1974 1288
118. K. Terada S. Kawano K. Yoshihiro Varicella-zoster virus (VZV) reactivation is related to the low response of VZV-specific immunity after chickenpox in infancy J Infect Dis 169 1995 650
119. M. Tsolia A.A. Gershon S.P. Steinberg Live attenuated varicella vaccine: Evidence that the virus is attenuated and the importance of skin lesions in transmission of Varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group J Pediatr 116 1990 184
120. T. Vesikari A. Ohrling M. Bear Evaluation of live attenuated varicella vaccine (Oka-RIT strain) and combined varicella and MMR vaccination in 13-17-month-old children Act a Paediatr Scand 80 1991 1051
121. M.R. Wallace I. Woelfl W.A. Bowler Tumor necrosis factor, interleukin-2 and interferon-gamma in adult varicella J Med Virol 43 1994 69 71
122. B. Watson C. Boardman D. Laufer Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine Clin Infect Dis 20 2 1995 316
123. B. Watson R. Gupta T. Randall Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine J Infect Dis 169 1994 197
124. B. Watson P.M. Keller R.W. Ellis Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: Kinetics and specificity J Infect Dis 162 1990 794
125. B.M. Watson S.A. Piercy S.A. Plotkin Modified chickenpox in children immunized with the Oka/Merck varicella vaccine Pediatrics 91 1993 17
126. B. Watson S. Piercy D. Soppas The effect of decreasing amounts of live virus, while antigen content remains constant, on immunogenicity of Oka/Merck varicella vaccine J Infect Dis 168 1993 1356
127. A. Webster P. Grint M.K. Brenner Titration of IgG antibodies against varicella zoster virus before bone marrow transplantation is not predictive of future zoster J Med Virol 27 1989 117
128. R.E. Weibel B.J. Kuter B.J. Neff Live Oka/Merck varicella vaccine in healthy children: Further clinical and laboratory assessment JAMA 254 1985 2435
129. R.E. Weibel B.J. Neff B.J. Kuter Live attenuated varicella virus vaccine: Efficacy trial in healthy children N Engl J Med 310 1984 1409
130. K.A. Weigle C. Grose Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation J Infect Dis 149 1984 741
131. C.J. White B.J. Kuter C.S. Hildebrand Varicella vaccine (VARIVAX) in healthy children and adolescents: Results from clinical trials, 1987 to 1989 Pediatrics 87 1991 604
132. C.J. White B.J. Kuter A. Ngai Modified cases of chickenpox after varicella vaccination: Correlation of protection with antibody response Pediatr Infect Dis J 11 1992 19
133. R.J. Whitley Varicella-zoster virus, 235 G. Galasso R. Whitley T.C. Merigan Antiviral Agents and Viral Diseases of Man 1990 Raven Press New York 235 264
134. V. Williams A.A. Gershon P.A. Brunell Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence J Infect Dis 130 1974 669
135. A. Wilson M. Sharp C.M. Koropchak Subclinical varicella-zoster virus viremia, herpes zoster and recovery of T-lymphocyte responses to varicella-zoster viral antigens after allogeneic and autologous bone marrow transplantation J Infect Dis 165 1992 119
136. A.E. Wittek A.M. Arvin C.M. Koropchak Serum immunoglobulin A antibody to varicella-zoster virus with primary varicella, herpes zoster, and in immune subjects J Clin Microbiol 18 1983 1146
137. J.A. Zaia M.J. Levin S.R. Preblud Evaluation of varicella-zoster immune globulin: Protection of immunosuppressed children after household exposure to varicella J Infect Dis 147 1983 737
138. I. Zamora J.M. Simon S.M. Da Attenuated varicella virus vaccine in children with renal transplants Pediatr Nephrol 8 1994 190
139. Y. Zhang M. Cosyns M.J. Levin Cytokine production in varicella-zoster virus-stimulated limiting dilution lymphocyte cultures Clin Exp Immunol 98 1994 128
140. H. Zweerink B.J. Neff Immune response after exposure to varicella-zoster virus: Characterization of virus-specific antibodies and their corresponding antigens Infect Immun 31 1981 436